Investigating the Frequency and Association of BACE1-AS rs147542312C/T with Alzheimer's Disease in Northwest of Iran
Journal Title: International Neuropsychiatric Disease Journal - Year 2017, Vol 10, Issue 2
Abstract
Background and Aims: Alzheimer’s disease is the most common neurodegenerative disorder worldwide. The long noncoding RNA, BACE1-AS, acts as a regulator of BACE1 transcript which its product involves in Alzheimer’s disease pathobiology. We investigated the frequency and association of rs147542312C/T of BACE1-AS gene with Alzheimer’s disease in northwest of Iran. Place and Duration of Study: Department of Genetics and Animal Biology (Faculty of Natural Science, University of Tabriz) and Neurosciences Research Center, Tabriz University of Medical Sciences, between February 2016 and May 2017. Methodology: Genomic DNA was extracted from peripheral blood cells of 180 people, including 87 cases and 93 healthy controls by standard salting out method. The samples were genotyped using tetra-primer as well as three-primer ARMS-PCR methods. To further verify the results, some samples were sequenced randomly. Tetra-primer and three-primer ARMS-PCR methods revealed no T allele either in cases or in controls and the results were verified with sequencing. Results: The results obtained showed that all cases and controls were genotypically CC homozygotes. This study did not reveal any association between the rs147542312C/T polymorphism of BACE1-AS with Alzheimer’s disease. So the rs147542312C/T polymorphism of BACE1-AS do not present or may occur in a very low frequency in northwest of Iran. Conclusion: The results imply that the rs147542312C/T polymorphism of BACE1-AS can’t be considered as an informative genetic change for prevalence of Alzheimer’s disease in northwest of Iran.
Authors and Affiliations
Mohammad Khalaj-Kondori, Maliheh Vafadoost, Mohammad-Ali Hosseinpour-Feizi, Mahnaz Talebi, Mehdi Farhoudi
Keywords
Related Articles
- EP ID EP308531
- DOI 10.9734/INDJ/2017/36597
- Views 124
- Downloads 0
Do Psychiatry and Family Medicine Residents Differ with Regard to Attitudes towards Treating Substance Use Patients
Background and Objective: Substance use disorders are a major health issue affecting many who present for treatment for psychiatric and medical problems. Substance use is associated with employment problems, relational d...
Familial Idiopathic Basal Ganglia Calcification (Fahr's syndrome): Initial Clinical Neuropsychiatric Presentation without Corresponding Neurological Deficit
Familial idiopathic basal ganglia calcification (FIBGC) or Fahr's syndrome is a rare disorder with various clinical presentations which can mimic - in particular - psychiatric illness. The following case is characterized...
Quality of Life of Subjects with Leprosy and Albinism
Background: Disfiguring skin disorders like leprosy and albinism may negatively distort a patient’s body image with resultant impairment in quality of life. Objective: This study determined and compared the quality of l...
Adolescents’ Disclosure of Sexual Violence Victimization in Nigeria: Prevalence, Barriers and Mental Health Implications
Aim: Despite the adverse mental health consequences of sexual violence, the majority of cases are unreported by victims. Non-disclosure prevents access to appropriate therapeutic and legal interventions. The design of in...
Socio-demographic and Clinical Predictors of Co-morbid Psychiatric Disorders in Patients with Epilepsy
Background: Association between epilepsy and psychiatry has a long history that required a comprehensive care of patients with epilepsy. This would include special attention to the psychological and social consequences b...